FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Warns of Sibutramine in Slimming Beauty Capsules

[ Price : $8.95]

FDA advises consumers against using Beautiful Health Inc.s Slimming Beauty Bitter Orange Slimming capsules because they contain th...

Abbott Pulling Meridia from U.S. Market

[ Price : $8.95]

Abbott pulls Meridia from the U.S. market at FDAs request due to increased risk of major adverse cardiovascular events.

Appeals Court to Hear CaretoLive Case Arguments

[ Price : $8.95]

A federal appeals court schedules oral arguments in CaretoLives case against FDA for failing to adequately search for documents so...

Musty Smelling Drug Products Spread to Pfizer

[ Price : $8.95]

Pfizer recalls seven lots of Lipitor after receiving complaints about a musty odor coming from product bottles.

Attorney Sees Increase in Park Doctrine Cases

[ Price : $8.95]

Attorney John Fleder says there are steps responsible corporate officials should take to try to avoid being prosecuted under the P...

Source Code Out for 2 CDRH Projects

[ Price : $8.95]

CDRH says public domain source code created by its employees is available for two computational research projects.

FDA Commits to Regulatory Science Advances

[ Price : $8.95]

FDA chief scientist Jesse Goodman outlines steps the agency will take to further develop its regulatory science capabilities.

Targacept Drug Fails ADHD Trial

[ Price : $8.95]

Targacept says its AZD 1446 failed to improve ADHD core symptoms in adults in a Phase 2 trial conducted by AstraZeneca.

FDA Approves Roxane's Generic Cozaar and Hyzaar

[ Price : $8.95]

FDA approves Roxane Laboratories ANDAs for generic copies of Merck's high blood pressure drugs Cozaar and Hyzaar.

FDA Clears Calypso Medical 510(k) for Prostate Radiotherapy

[ Price : $8.95]

FDA clears a Calypso Medical Technologies 510(k) for the Calypso System with Dynamic Edge Gating Technology to provide precise inf...